Showing results (3381-3390 of 9,338) with videos related to
Sort By:
Pageof 934
Cancer Medicine|January 14, 2014
Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinomaAndrew J Dalley, Luke P Pitty, Aidan G Major, et al.Cancer Medicine|June 21, 2014
Early inflammatory response in epithelial ovarian tumor cyst fluidsBjörg Kristjánsdóttir, Karolina Partheen, Eric T Fung, et al.Cancer Medicine|January 28, 2014
Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy responseNatalia Dubrowinskaja, Kai Gebauer, Inga Peters, et al.Cancer Medicine|June 20, 2014
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Helle Hjorth Johannesen, Dorte Nielsen, et al.Cancer Medicine|April 3, 2021
Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL TrialIan Cromwell, Laurie W Smith, Kim van der Hoek, et al.Cancer Medicine|April 7, 2021
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancerVikram Gota, Manjunath Nookala, Avinash Bonda, et al.Cancer Medicine|July 15, 2020
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI studySaroj Vadhan-Raj, Mairéad G McNamara, Marino Venerito, et al.Cancer Medicine|July 16, 2020
Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastomaSophie Richard, Gaëlle Tachon, Serge Milin, et al.Cancer Medicine|July 28, 2020
Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell linesAlexander Schepsky, Gunnhildur Asta Traustadottir, Jon Petur Joelsson, et al.Cancer Medicine|July 28, 2020
Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsilTingting Xu, Chunying Shen, Ye Wei, et al.Pageof 934